Jam Healthcare (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 5.00 M
as on 24-10-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.38 Cr
as on 24-10-2024
- Revenue 21.30%
(FY 2023)
- Profit 18.05%
(FY 2023)
- Ebitda -1512.32%
(FY 2023)
- Net Worth 1.53%
(FY 2023)
- Total Assets 11.82%
(FY 2023)
About Jam Healthcare (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹3.38 Cr.
Dharmendra Agarwal and Shilpa Agrawal serve as directors at the Company.
- CIN/LLPIN
U24232UP2010PTC040511
- Company No.
040511
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jam Healthcare (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmendra Agarwal  | Managing Director | 07-May-2010 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shilpa Agrawal | Director | 09-Dec-2016 | Current |
Financial Performance of Jam Healthcare (India).
Jam Healthcare (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.3% increase. The company also saw a substantial improvement in profitability, with a 18.05% increase in profit. The company's net worth moved up by a moderate rise of 1.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jam Healthcare (India)?
In 2023, Jam Healthcare (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vcb Life Sciences Private LimitedActive 6 years 2 monthsDharmendra Agarwal and Shilpa Agrawal are mutual person
- Garg Surgical Point Private LimitedActive 12 years 20 days
Dharmendra Agarwal and Shilpa Agrawal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 27 Jun 2024 | ₹2.00 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Apr 2024 | ₹0.30 M | Open |
Hdfc Bank Limited Creation Date: 07 Jun 2023 | ₹2.01 M | Open |
How Many Employees Work at Jam Healthcare (India)?
Unlock and access historical data on people associated with Jam Healthcare (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jam Healthcare (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jam Healthcare (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
